A specialty pharmaceutical manufacturer focused on branded and generic medicines, with historical strength in pain management, urology, and endocrinology products. The company has been closely watched by investors due to its exposure to opioid-related litigation and a major bankruptcy restructuring ...
1 member of Congress has disclosed 3 trades in Endo Intl Plc (ENDP), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-12-26 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-12-28 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-08-04 | MICHAEL T. MCCAUL | buy | $15K – $50K |